Cargando…
A novel trifunctional IgG-like bispecific antibody to inhibit HIV-1 infection and enhance lysis of HIV by targeting activation of complement
BACKGROUND: The complement system is not only a key component of innate immunity but also provides a first line of defense against invading pathogens, especially for viral pathogens. Human immunodeficiency virus (HIV), however, possesses several mechanisms to evade complement-mediated lysis (CoML) a...
Autores principales: | Jia, Leili, Xu, Yuanyong, Zhang, Chuanfu, Wang, Yong, Chong, Huihui, Qiu, Shaofu, Wang, Ligui, Zhong, Yanwei, Liu, Weijing, Sun, Yansong, Qiao, Fei, Tomlinson, Stephen, Song, Hongbin, Zhou, Yusen, He, Yuxian |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904741/ https://www.ncbi.nlm.nih.gov/pubmed/20584336 http://dx.doi.org/10.1186/1743-422X-7-142 |
Ejemplares similares
-
A novel approach to inhibit HIV-1 infection and enhance lysis of HIV by a targeted activator of complement
por: Xu, Yuanyong, et al.
Publicado: (2009) -
A new therapeutic strategy for lung tissue injury induced by influenza with CR2 targeting complement inhibitior
por: Zhang, Chuanfu, et al.
Publicado: (2010) -
A new treatment for neurogenic inflammation caused by EV71 with CR2-targeted complement inhibitor
por: Qiu, Shaofu, et al.
Publicado: (2012) -
Development of tumor lysis syndrome (TLS): A potential risk factor in cancer patients receiving anticancer therapy
por: Rasool, Mahmood, et al.
Publicado: (2014) -
Pre-exposure chemoprophylaxis for HIV: It is time
por: Smith, Stephen M
Publicado: (2004)